The German Cancer Research Center (DKFZ) is, with more than 3,000 employees, the largest biomedical research facility in Germany. More than 1,000 scientists at DKFZ conduct research on how cancer emerges, ascertain cancer-risk factors, and look for new strategies that prevent individuals from getting cancer. They are currently developing new methods with which tumours can be diagnosed more precisely, and cancer patients can be treated more successfully.
Employees at the Krebsinformationsdienst (KID) explain the widespread disease cancer to patients, family members and interested citizens. Jointly with the University Clinic Heidelberg, the DKFZ has installed the National Center for Tumour Diseases (NCT) Heidelberg , in which promising approaches from cancer research are transferred into the clinic. In the German Consortium for Translational Cancer Research (DKTK), one of the six German centers for health research, the DKFZ maintains translation centers at seven university partner sites.
The bonding of excellent university medicine with top-level research at a Helmholtz Center represents a significant contribution towards improving opportunities for cancer patients. The DKFZ is financed 90 percent by the Federal Ministry of Education and Research and 10 percent by the Federal State Baden-Württemberg, and is a member of the Helmholtz Association of German Research Centers.